Expert Interview
A Second Look: Discussing the abstract data on the Phase 2a Study Of TMS-007, an SMTP family anti-inflammatory prothrombolytic, on patients with Acute Ischemic Stroke (AIS) up to 12 hours after onset
Ticker(s): JI-XING, BIIBInstitution: New York Presbyterian Medical Center
- Vascular neurologist and an assistant professor of clinical neurology at Weill Cornell Medicine
- Clinical interest in management and prevention of stroke, intracerebral hemorrhage, and stroke in young adults
- Graduated from New York Institute of Technology College of Osteopathic Medicine, Residency in neurology at NorthWell Health, Fellowship in vascular neurology and stroke at Montefiore Medical Center.
- Manages over 100 patients on anticoagulation medications
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
